Clinician’s take on the promise of therapeutic CRISPR editing in humans

| | April 14, 2014
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A powerful new genetics tool has the potential to correct human disease in a way that was unimaginable a few years ago.

This new technique involves gene editing — correcting mistakes in mutated DNA — to restore normal cell function. The enabling discovery is a biological system called CRISPR-Cas, which was discovered during research on bacterial immune systems.

Bacteria must defend themselves against viruses and other foreign invaders, just as we do. Most types of bacteria have the ability to cut invading, harmful virus DNA away from the bacterial host DNA.

The prospect of human clinical trials seems likely in a few years. The diseases amenable to this approach might number in the hundreds or thousands.

Read the full, original story: Pediatric research | Genetic editing promises to correct DNA mistakes

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend